Vantage Consulting Group’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Sell |
|
|||||
|
2025
Q1 | $1.2M | Hold |
|
|||||
|
2024
Q4 | $1.69M | Hold |
|
|||||
|
2024
Q3 | $2.68M | Hold |
|
|||||
|
2024
Q2 | $2.69M | Hold |
|
|||||
|
2024
Q1 | $3.82M | Hold |
|
|||||
|
2023
Q4 | $1.41M | Hold |
|
|||||
|
2023
Q3 | $763K | Sell |
|
|||||
|
2023
Q2 | $1.9M | Sell |
|
|||||
|
2023
Q1 | $2.31M | Hold |
|
|||||
|
2022
Q4 | $4.56M | Hold |
|
|||||
|
2022
Q3 | $5.72M | Hold |
|
|||||
|
2022
Q2 | $9.43M | Sell |
|
|||||
|
2022
Q1 | $24.7M | Hold |
|
|||||
|
2021
Q4 | $33.9M | Hold |
|
|||||
|
2021
Q3 | $45.6M | Hold |
|
|||||
|
2021
Q2 | $40.9M | Hold |
|
|||||
|
2021
Q1 | $41M | Hold |
|
|||||
|
2020
Q4 | $53.8M | Buy |
|